Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Natalia Perekhvatova"'
Autor:
Yi Wei, Andrew Troger, Viola Spahiu, Natalia Perekhvatova, Maxim Skulachev, Anton Petrov, Boris Chernyak, Penny Asbell
Publikováno v:
Ophthalmology and Therapy, Vol 8, Iss 1, Pp 63-73 (2018)
Abstract Introduction SkQ1 (Visomitin) is a novel mitochondrial-targeted antioxidant that holds promise in the treatment of inflammation associated with ocular surface diseases such as dry eye disease (DED) and corneal wounds. However, the specific r
Externí odkaz:
https://doaj.org/article/aa95740a36d64083a402f2e5ad2f2b5a
Autor:
Andrew Troger, Anton Petrov, Natalia Perekhvatova, Viola Spahiu, Maxim V. Skulachev, Penny A. Asbell, Yi Wei, Boris V. Chernyak
Publikováno v:
Ophthalmology and Therapy, Vol 8, Iss 1, Pp 63-73 (2018)
Ophthalmology and Therapy
Ophthalmology and Therapy
Introduction SkQ1 (Visomitin) is a novel mitochondrial-targeted antioxidant that holds promise in the treatment of inflammation associated with ocular surface diseases such as dry eye disease (DED) and corneal wounds. However, the specific role of Sk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e6d5874eccf3e6433f660381cde52d
https://doi.org/10.1007/s40123-018-0158-2
https://doi.org/10.1007/s40123-018-0158-2
Publikováno v:
Advances in Therapy
Introduction This Phase 2 clinical trial assessed the efficacy and safety of the novel antioxidative, renewable compound SkQ1 for topical treatment of dry eye signs and symptoms. Methods In a single-center, randomized, double-masked, placebo-controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0904ded89daf6a9ee8bcfed54e8d59